Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Cancer Chemotherapy and Pharmacology|January 17, 2012
The effect of aprepitant and race on the pharmacokinetics of cyclophosphamide in breast cancer patientsChristine M Walko, Austin J Combest, Ivan Spasojevic, et al.
The Oncologist|February 10, 2017
Key Lessons Learned from Moffitt's Molecular Tumor Board: The Clinical Genomics Action Committee ExperienceTodd C Knepper, Gillian C Bell, J Kevin Hicks, et al.
Cancer Chemotherapy and Pharmacology|February 8, 2007
Phase I and pharmacokinetic trial of carboplatin and albumin-bound paclitaxel, ABI-007 (Abraxane) on three treatment schedules in patients with solid tumorsThomas E Stinchcombe, Mark A Socinski, Christine M Walko, et al.
Cancer Chemotherapy and Pharmacology|March 26, 2011
Pharmacologic and phenotypic study of docetaxel in patients with ovarian or primary peritoneal cancerWilliam C Zamboni, Austin J Combest, Julie A DeLoia, et al.
Cancer Chemotherapy and Pharmacology|November 22, 2017
The impact of skeletal muscle on the pharmacokinetics and toxicity of 5-fluorouracil in colorectal cancerGrant R Williams, Allison M Deal, Shlomit Strulov Shachar, et al.
Lung Cancer (Amsterdam, Netherlands)|June 29, 2010
A phase I trial of sorafenib combined with cisplatin/etoposide or carboplatin/pemetrexed in refractory solid tumor patientsJanine M Davies, Nirav S Dhruva, Christine M Walko, et al.
European Journal of Cancer (Oxford, England : 1990)|August 24, 2010
Amplification of thymidylate synthetase in metastatic colorectal cancer patients pretreated with 5-fluorouracil-based chemotherapyRoshawn G Watson, Filipe Muhale, Leigh B Thorne, et al.
Pageof 5